-
EP1423145
European procedure
Extract from the Register of European Patents
EP About this file: EP1423145
| EP1423145 - COMPOSITIONS FOR THE TREATMENT OF PARKINSON'S DISEASE CONTAINING A CB1 RECEPTOR ANTAGONIST AND A PRODUCT THAT ACTIVATES DOPAMINERGIC NEUROTRANSMISSION IN THE BRAIN [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 13.04.2007 Database last updated on 14.06.2024 | Most recent event Tooltip | 05.10.2007 | Change - lapse in a contracting state State(s) deleted from list of lapses: IT | published on 07.11.2007 [2007/45] | Applicant(s) | For all designated states Aventis Pharma S.A. 20, avenue Raymond Aron 92160 Antony / FR | [2004/23] | Inventor(s) | 01 /
BENAVIDES, Jésus 105 rue Anatole France F-92280 Chatenay-Malabry / FR | 02 /
BOCCIO, Daniel 27, rue Lourdeau F-77310 Pringy / FR | 03 /
HENIN, Yvette 18 Cours du 7ème Art F-75019 Paris / FR | 04 /
PIOT-GROSJEAN, Odile 12, rue Guy Moquet F-94600 Choisy le Roi / FR | [2005/49] |
| Former [2004/38] | 01 /
BENAVIDES, Jésus 47, avenue de Seine F-92500 Rueil-Malmaison / FR | ||
| 02 /
BOCCIO, Daniel 27, rue Lourdeau F-77310 Pringy / FR | |||
| 03 /
HENIN, Yvette 18 Cours du 7ème Art F-75019 Paris / FR | |||
| 04 /
PIOT-GROSJEAN, Odile 12, rue Guy Moquet F-94600 Choisy le Roi / FR | |||
| Former [2004/23] | 01 /
BENAVIDES, Jésus 47, avenue de Seine F-92500 Rueil-Malmaison / FR | ||
| 02 /
BOCCIO, Daniel 27, rue Lourdeau F-77310 Pringy / FR | |||
| 03 /
HENIN, Yvette 12, rue Duchefdelaville F-75013 Paris / FR | |||
| 04 /
PIOT-GROSJEAN, Odile 12, rue Guy Moquet F-94600 Choisy le Roi / FR | Representative(s) | Rousseau, Pierick Edouard Aventis Pharma S.A. Direction des Brevets Tri LEO/144 20, avenue Raymond Aron 92165 Antony Cedex / FR | [N/P] |
| Former [2004/23] | Rousseau, Pierrick Edouard Aventis Pharma S.A. Direction des Brevets, Tri LEO/144 20, avenue Raymond Aron 92165 Antony Cedex / FR | Application number, filing date | 02772514.2 | 28.08.2002 | [2004/23] | WO2002FR02946 | Priority number, date | FR20010011200 | 29.08.2001 Original published format: FR 0111200 | [2004/23] | Filing language | FR | Procedural language | FR | Publication | Type: | A1 Application with search report | No.: | WO03020314 | Date: | 13.03.2003 | Language: | FR | [2003/11] | Type: | A1 Application with search report | No.: | EP1423145 | Date: | 02.06.2004 | Language: | FR | The application published by WIPO in one of the EPO official languages on 13.03.2003 takes the place of the publication of the European patent application. | [2004/23] | Type: | B1 Patent specification | No.: | EP1423145 | Date: | 07.06.2006 | Language: | FR | [2006/23] | Search report(s) | International search report - published on: | EP | 13.03.2003 | Classification | IPC: | A61K45/06, A61P25/16, A61K31/4353, A61K31/397 | [2005/45] | CPC: |
A61K9/4858 (EP,US);
A61K31/397 (EP,US);
A61K31/4353 (EP,US);
A61K45/06 (EP,US);
A61P25/00 (EP);
A61P25/16 (EP);
A61P43/00 (EP)
(-)
| C-Set: |
A61K31/397, A61K2300/00 (EP,US);
A61K31/4353, A61K2300/00 (US,EP) |
| Former IPC [2004/23] | A61K45/06, A61P25/16 | Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, SK, TR [2004/23] | Extension states | AL | Not yet paid | LT | Not yet paid | LV | Not yet paid | MK | Not yet paid | RO | Not yet paid | SI | Not yet paid | Title | German: | ZUSAMMENSETZUNGEN ZUR BEHANDLUNG VON PARKINSON'S KRANKHEIT, WELCHE ANTAGONISTEN DER CB1-REZEPTOREN UND AKTIVIERUNGSSUBSTANZEN DER DOPAMIN-NEUROTRANSMISSION IM GEHIRN ENTHALTEN | [2004/23] | English: | COMPOSITIONS FOR THE TREATMENT OF PARKINSON'S DISEASE CONTAINING A CB1 RECEPTOR ANTAGONIST AND A PRODUCT THAT ACTIVATES DOPAMINERGIC NEUROTRANSMISSION IN THE BRAIN | [2004/23] | French: | COMPOSITIONS POUR LE TRAITEMENT DE LA MALADIE DE PARKINSON CONTENANT UN ANTAGONISTE DU RECEPTEUR CB1 ET UN PRODUIT QUI ACTIVE LA NEUROTRANSMISSION DOPAMINERGIQUE DANS LE CERVEAU | [2004/23] | Entry into regional phase | 29.03.2004 | National basic fee paid | 29.03.2004 | Designation fee(s) paid | 29.03.2004 | Examination fee paid | Examination procedure | 17.03.2003 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 29.03.2004 | Examination requested [2004/23] | 05.07.2004 | Despatch of a communication from the examining division (Time limit: M06) | 24.12.2004 | Reply to a communication from the examining division | 24.10.2005 | Communication of intention to grant the patent | 03.03.2006 | Fee for grant paid | 03.03.2006 | Fee for publishing/printing paid | Divisional application(s) | EP06000097.3 / EP1649849 | Opposition(s) | 08.03.2007 | No opposition filed within time limit [2007/20] | Fees paid | Renewal fee | 31.08.2004 | Renewal fee patent year 03 | 31.08.2005 | Renewal fee patent year 04 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | deleted | [2007/45] |
| Former [2007/39] | IT | 07.06.2006 | Cited in | International search | [X] - SANUDO-PENA, M. CLARA ET AL, "A novel neurotransmitter system involved in the control of motor behavior by the basal ganglia", ANN. N. Y. ACAD. SCI. (1998), 860(NEURONAL MECHANISMS FOR GENERATING LOCOMOTOR ACTIVITY), 475-479, XP008002762 [X] 1 * page 478, paragraph 2 * DOI: http://dx.doi.org/10.1111/j.1749-6632.1998.tb09081.x | [X] - MESCHLER, JUSTIN P. ET AL, "D2, but not D1 dopamine receptor agonists potentiate cannabinoid-induced sedation in nonhuman primates", JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2000), 292(3), 952-959, XP008002761 [X] 1 * page 955, column 2, paragraph 2 - page 958, column 2 * | [X] - DI MARZO V ET AL, "Enhanced levels of endogenous cannabinoids in the globus pallidus are associated with a reduction in movement in an animal model of Parkinson's disease.", FASEB JOURNAL, (2000 JUL) 14 (10) 1432-8., XP001075032 [X] 1 * abstract * DOI: http://dx.doi.org/10.1096/fj.14.10.1432 | [X] - BROTCHIE, J. M. ET AL, "The cannabinoid receptor antagonist SR141716A reduces L - DOPA -induced dyskinesia in the MPTP-treated primate model of Parkinson's disease.", BRITISH JOURNAL OF PHARMACOLOGY, (MARCH, 1998) VOL. 123, NO. PROC. SUPPL. PP. 66P. MEETING INFO.: MEETING OF THE BRITISH PHARMACOLOGICAL SOCIETY HELD JOINTL WITH DUTCH PHARMACOLOGICAL SOCIETY, THE BELGIAN SOCIETY FOR FUNDAMENTAL AND CLINICAL PHYSIOLO, XP008002758 [X] 1 * the whole document * |